Compounds > cysteamine
Page last updated: 2024-08-17

cysteamine and paclitaxel

cysteamine has been researched along with paclitaxel in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ozcan Arican, G1
Abd Kadir, E; Ayub, AD; Chiu, HI; Lim, V; Mat Yusuf, SNA; Ngalim, SH1

Reviews

1 review(s) available for cysteamine and paclitaxel

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

3 other study(ies) available for cysteamine and paclitaxel

ArticleYear
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
Cytoprotective effects of amifostine and cysteamine on cultured normal and tumor cells treated with paclitaxel in terms of mitotic index and 3H-thymidine labeling index.
    Cancer chemotherapy and pharmacology, 2005, Volume: 56, Issue:2

    Topics: Amifostine; Animals; Antineoplastic Agents, Phytogenic; Cysteamine; Fibroblasts; HeLa Cells; Humans; Mice; Mice, Inbred BALB C; Mitotic Index; Paclitaxel; Radiation-Protective Agents; Thymidine; Tumor Cells, Cultured

2005
Biocompatible disulphide cross-linked sodium alginate derivative nanoparticles for oral colon-targeted drug delivery.
    Artificial cells, nanomedicine, and biotechnology, 2019, Volume: 47, Issue:1

    Topics: Administration, Oral; Alginates; Biocompatible Materials; Biological Transport; Colon; Cysteamine; Disulfides; Drug Carriers; Drug Liberation; Drug Stability; HT29 Cells; Humans; Hydrogen-Ion Concentration; Nanoparticles; Nanospheres; Paclitaxel; Particle Size; Surface Properties

2019